Page last updated: 2024-08-22

magnesium sulfate and Basal Ganglia Cerebrovascular Disease

magnesium sulfate has been researched along with Basal Ganglia Cerebrovascular Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gianopoulos, JG; Kuban, K; Mittendorf, R; Pryde, PG; Yousefzadeh, D1
Dammann, O; Lee, KS; Mittendorf, R1

Reviews

1 review(s) available for magnesium sulfate and Basal Ganglia Cerebrovascular Disease

ArticleYear
Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor.
    Journal of perinatology : official journal of the California Perinatal Association, 2006, Jan-01, Volume: 26, Issue:1

    Topics: Basal Ganglia Cerebrovascular Disease; Cerebral Hemorrhage; Cerebral Palsy; Female; Humans; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Prenatal Exposure Delayed Effects; Randomized Controlled Trials as Topic; Tocolytic Agents

2006

Trials

1 trial(s) available for magnesium sulfate and Basal Ganglia Cerebrovascular Disease

ArticleYear
Antenatal risk factors associated with the development of lenticulostriate vasculopathy (LSV) in neonates.
    Journal of perinatology : official journal of the California Perinatal Association, 2005, Volume: 25, Issue:2

    Topics: Adult; Basal Ganglia Cerebrovascular Disease; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Prospective Studies; Risk Factors; Tocolytic Agents

2005